<p>Curaleaf Holdings, Inc. (OTCMKTS:CURLF - 获取免费报告) 在周一市场开盘前出现了下跌缺口。该股票之前收于 $2.37，但开盘价为 $2.21。Curaleaf 的股票最后交易价格为 $2.25，成交量为 45,165 股。</p>
<h2>分析师设定新的价格目标</h2>
<ul>
<li>大麻股票反弹的机会：幻想还是机会？</li>
</ul>
<p>几位股票研究分析师最近对该股票发表了评论。Zacks Research 在 1 月 1 日的研究报告中将 Curaleaf 的评级从 “强烈卖出” 上调至 “持有”。ATB Cormark Capital Markets 在 12 月 2 日的研究报告中将 Curaleaf 的评级上调至 “跑赢大盘”。最后，Alliance Global Partners 在 12 月 22 日的报告中重新发布了对 Curaleaf 的 “买入” 评级。两位分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，一位给予 “持有” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “买入”。</p>
<p><strong>查看我们关于 Curaleaf 的最新报告</strong></p>
<h2>Curaleaf 股价下跌 4.2%</h2>
<ul>
<li>三只准备蓬勃发展的大麻股票</li>
</ul>
<p>该公司的债务与股本比率为 1.14，速动比率为 0.76，流动比率为 1.52。该公司的 50 日简单移动平均线为 $2.45，200 日简单移动平均线为 $2.68。该公司的市值为 15.4 亿美元，市盈率为 -7.57，贝塔系数为 0.71。</p>
<p>Curaleaf (OTCMKTS:CURLF - 获取免费报告) 最近在 2 月 26 日发布了季度财报。该公司报告每股收益（EPS）为 ($0.05)，超出分析师共识预期的 ($0.08) 0.03 美元。该公司季度收入为 3.3307 亿美元，而共识预期为 3.2870 亿美元。Curaleaf 的净利润率为 -18.08%，股本回报率为 -23.17%。股票研究分析师预测 Curaleaf Holdings, Inc. 今年的每股收益将为 -0.25。</p>
<h2>Curaleaf 公司简介</h2>
<p>(获取免费报告)</p>
<ul>
<li>SAFE 法案能否点燃大麻行业的高期望？</li>
</ul>
<p>Curaleaf Holdings, Inc 是一家领先的美国大麻公司，专注于医疗和成人使用大麻产品的种植、加工和分销。公司总部位于马萨诸塞州的韦克菲尔德，Curaleaf 在多个美国司法管辖区运营种植设施、加工中心和零售药房。公司的垂直整合模式使其能够管理整个供应链，从种子到销售，确保一致的质量和符合严格的监管要求。</p>
<p>Curaleaf 的产品组合涵盖多种形式，包括优质花朵、蒸汽烟雾器、食用产品、酊剂、外用药和浓缩物。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过 Curaleaf</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>埃隆·马斯克已经让我成为 “富有的人”</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 $1,000 在 Curaleaf 吗？</h2>
<p>在你考虑投资 Curaleaf 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Curaleaf 并不在名单上。</p>
<p>虽然 Curaleaf 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CURLF

<p>Curaleaf Holdings, Inc.（OTCMKTS:CURLF）股价从 2.37 美元跳空下跌至 2.21 美元，随后交易于 2.25 美元。分析师的评级不一，Zacks 将评级上调至 “持有”，而 ATB Cormark 则上调至 “跑赢大盘”。Curaleaf 报告的季度每股收益为（0.05 美元），超出预期，收入为 3.3307 亿美元。该公司的市值为 15.4 亿美元，净利润率为负 18.08%。尽管当前的共识为 “买入”，但一些分析师建议存在更好的投资机会</p>

<p>Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $2.37, but opened at $2.21. Curaleaf shares last traded at $2.25, with a volume of 45,165 shares changing hands.</p>
<div class="lb-trans"><p>Curaleaf Holdings, Inc. (OTCMKTS:CURLF - 获取免费报告) 在周一市场开盘前出现了下跌缺口。该股票之前收于 $2.37，但开盘价为 $2.21。Curaleaf 的股票最后交易价格为 $2.25，成交量为 45,165 股。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新的价格目标</h2>
</div><ul>
<li>Cannabis Stocks Up for Reversal: Pipedreams or Opportunity?</li>
</ul>
<div class="lb-trans"><ul>
<li>大麻股票反弹的机会：幻想还是机会？</li>
</ul>
</div><p>Several equities research analysts have recently commented on the stock. Zacks Research raised shares of Curaleaf from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, January 1st. ATB Cormark Capital Markets raised shares of Curaleaf to an &#34;outperform&#34; rating in a research report on Tuesday, December 2nd. Finally, Alliance Global Partners reissued a &#34;buy&#34; rating on shares of Curaleaf in a report on Monday, December 22nd. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company currently has a consensus rating of &#34;Buy&#34;.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该股票发表了评论。Zacks Research 在 1 月 1 日的研究报告中将 Curaleaf 的评级从 “强烈卖出” 上调至 “持有”。ATB Cormark Capital Markets 在 12 月 2 日的研究报告中将 Curaleaf 的评级上调至 “跑赢大盘”。最后，Alliance Global Partners 在 12 月 22 日的报告中重新发布了对 Curaleaf 的 “买入” 评级。两位分析师给予该股票 “强烈买入” 评级，一位给予 “买入” 评级，一位给予 “持有” 评级。根据 MarketBeat 的数据，该公司的共识评级为 “买入”。</p>
</div><p><strong>View Our Latest Report on Curaleaf</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Curaleaf 的最新报告</strong></p>
</div><h2>Curaleaf Trading Down 4.2%</h2>
<div class="lb-trans"><h2>Curaleaf 股价下跌 4.2%</h2>
</div><ul>
<li>3 Growing Cannabis Stocks Ready To Bloom</li>
</ul>
<div class="lb-trans"><ul>
<li>三只准备蓬勃发展的大麻股票</li>
</ul>
</div><p>The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.76 and a current ratio of 1.52. The firm has a 50 day simple moving average of $2.45 and a two-hundred day simple moving average of $2.68. The firm has a market capitalization of $1.54 billion, a P/E ratio of -7.57 and a beta of 0.71.</p>
<div class="lb-trans"><p>该公司的债务与股本比率为 1.14，速动比率为 0.76，流动比率为 1.52。该公司的 50 日简单移动平均线为 $2.45，200 日简单移动平均线为 $2.68。该公司的市值为 15.4 亿美元，市盈率为 -7.57，贝塔系数为 0.71。</p>
</div><p>Curaleaf (OTCMKTS:CURLF - Get Free Report) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. The firm had revenue of $333.07 million for the quarter, compared to the consensus estimate of $328.70 million. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 23.17%. Equities research analysts forecast that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.</p>
<div class="lb-trans"><p>Curaleaf (OTCMKTS:CURLF - 获取免费报告) 最近在 2 月 26 日发布了季度财报。该公司报告每股收益（EPS）为 ($0.05)，超出分析师共识预期的 ($0.08) 0.03 美元。该公司季度收入为 3.3307 亿美元，而共识预期为 3.2870 亿美元。Curaleaf 的净利润率为 -18.08%，股本回报率为 -23.17%。股票研究分析师预测 Curaleaf Holdings, Inc. 今年的每股收益将为 -0.25。</p>
</div><h2>Curaleaf Company Profile</h2>
<div class="lb-trans"><h2>Curaleaf 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><ul>
<li>Can The SAFE Act Light Up High Hopes For Cannabis Industry?</li>
</ul>
<div class="lb-trans"><ul>
<li>SAFE 法案能否点燃大麻行业的高期望？</li>
</ul>
</div><p>Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company's vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.</p>
<div class="lb-trans"><p>Curaleaf Holdings, Inc 是一家领先的美国大麻公司，专注于医疗和成人使用大麻产品的种植、加工和分销。公司总部位于马萨诸塞州的韦克菲尔德，Curaleaf 在多个美国司法管辖区运营种植设施、加工中心和零售药房。公司的垂直整合模式使其能够管理整个供应链，从种子到销售，确保一致的质量和符合严格的监管要求。</p>
</div><p>Curaleaf's product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.</p>
<div class="lb-trans"><p>Curaleaf 的产品组合涵盖多种形式，包括优质花朵、蒸汽烟雾器、食用产品、酊剂、外用药和浓缩物。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Curaleaf</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>Elon Musk already made me a “wealthy man”</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过 Curaleaf</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>埃隆·马斯克已经让我成为 “富有的人”</li>
<li>巴菲特、盖茨和贝索斯悄悄抛售股票——原因在这里</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Curaleaf Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Curaleaf 吗？</h2>
</div><p>Before you consider Curaleaf, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑投资 Curaleaf 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Curaleaf 并不在名单上。</p>
</div><p>While Curaleaf currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Curaleaf 目前在分析师中获得了 “买入” 评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Curaleaf (OTCMKTS:CURLF) 股价跳空下跌 - 接下来会如何发展？